Inflammatory bowel disease (IBD) has been gradually considered a public health challenge worldwide. Sulfated polysaccharides, extracted from seaweed, have been shown to have an anti-inflammatory effect on the disease. In this study, LMW-ulvan, a unique sulfate Ulva polysaccharide with low molecular weight, was prepared using the enzymatic method. The structural characterization of LMW-ulvan and its protective effect on colitis induced by dextran sulfate sodium (DSS) were studied. The results showed that LMW-ulvan with molecular weight of 2.56 kDa consists of 57.23% rhamnose (Rha), 28.76% xylose (Xyl), 7.42% glucuronic acid (GlcA), and 1.77% glucose (Glc). Its backbone contains (1→3,4)-linked Rha, (1→4)-linked Xyl, and (1→4)-linked GlcA with small amounts of (1→4)-linked Rha residues; sulfate substitution was at C-3 of Rha. LMW-ulvan was found to reduce DSS-induced disease activity index, colon shortening, and colonic tissue damage, which were associated with decreased oxidative stresses and inflammation, thus improving the expression of tight junction proteins. These results indicate that LMW-ulvan is able to improve colitis and may be a promising application for IBD.

Polysaccharide chromium (III) derivatives are gaining increasing attention in improving type 2 diabetes. In this study, the sulfated polysaccharide from Enteromorpha prolifera (SPE) with 4.8 kDa was prepared by specific enzymatic hydrolysis. The obtained SPE was used to prepare a rhamnan-type sulfated polysaccharide derivative (SPED). Results indicated that O-H, C=O, and S=O were effectively involved in the chelation of SPED (chromium content 20.26%). Acute (half lethal dose > 2.38 g/kg) and sub-acute toxicity showed that SPED had no damaging effects on mice. Anti-diabetic experiment demonstrated that SPED improved glucose metabolism. Moreover, SPED promoted the PI3K/PKB/GSK-3β signaling pathway by regulating mRNA expression of insulin receptors (IR), insulin receptor substrate 2 (IRS-2), phosphatidylinositol 3 kinase (PI3K), protein kinase B (PKB), and glycogen synthase kinase 3β (GSK-3β). In conclusion, the SPED might represent a novel marine-derived candidate against hyperglycemia, which may undergo further pharmaceutical development as a hypoglycemic agent.

The immunomodulatory effects of R-phycoerythrin (R-PE) from Porphyra haitanensis were investigated by a hydrocortisone (HC)-induced immunosuppressive model in the present research. The results showed that R-PE had immunomodulatory potential, such as increasing spleen and thymus indexes, ameliorating spleen morphology, enhancing the phagocytic capability of macrophages, promoting spleen T lymphocyte proliferation, and strengthening serum hemolysin formation. Furthermore, R-PE elevated the CD4⁺/CD8⁺ ratio and up-regulated the levels of cytokines for Th1, Th2, and Th17 and the mRNA expression of transcription factors T-bet, GATA3, and RORγt. Besides, the levels of cytokines for Treg and transcription factor Foxp3 were down-regulated. The levels of T-bet/GATA3 and RORγt/Foxp3 were increased. R-PE activated the phosphorylation of NF-κB through the TLR4-mediated differentiation pathway. These findings suggested that R-PE exerted immunomodulatory activities in the innate and adaptive immune systems through TLR4/NF-κB mediated CD4⁺ T cell activation and differentiation, which facilitated the further application of R-PE as an immunomodulator.